Home › Ovarian Epithelial Carcinoma › Georgia
Ovarian Epithelial Carcinoma clinical trials in Georgia
3 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in Georgia.
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Nancy N. & J.C Lewis Cancer & Research Pavillion- St. Josephs/ Candler Health System, Savannah
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 2, 2026 · NCT06819007CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Winship Cancer Institute, Emory University, Atlanta
RecruitingPhase 2
Ages 18 and older · Women · Updated Dec 23, 2025 · NCT06690775A Beta-only IL-2 ImmunoTherapY Study
- Emory - Winship Cancer Institute, Atlanta
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 9, 2025 · NCT05086692From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.